ISL2 is an epigenetically silenced tumor suppressor and regulator of metabolism in pancreatic cancer
Turan Tufan(University of Virginia), Mazhar Adli(Northwestern University)
Cited by 2
Related Papers
IKKα and IKKβ Each Function to Regulate NF-κB Activation in the TNF-Induced/Canonical Pathway
|PLoS ONE|2010|116
CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
|Nature Communications|2018|78
Depletion of lamins B1 and B2 promotes chromatin mobility and induces differential gene expression by a mesoscale-motion-dependent mechanism
|Genome biology|2024|35